Helmerich & Payne (HP) is back in focus after management flagged fiscal Q4 segment margins at or near the high end of guidance and introduced a larger FlexRobotics deployment with ExxonMobil.
For Helmerich & Payne, the latest guidance on fiscal Q4 margins and the expanded FlexRobotics rollout with ExxonMobil come against a share price of $39.64, with a 7 day share price return of 6.73% and a 90 day share price return of 21.04%. This contrasts with a softer 30 day share price return, which declined 10.64%. Over a longer window, momentum still leans positive, with a year to date share price return of 32.40% and a 1 year total shareholder return of 71.47%. This suggests investors have been rewarding the combination of operational execution, technology uptake and capital discipline, even as shorter term swings reshape the entry point.
Scan beyond Helmerich & Payne to identify other drilling and energy contractors with similar momentum and balance sheet traits using our curated list of solid balance sheet and fundamentals (25 results)
Helmerich & Payne now trades at a discount to both analyst targets and some intrinsic value estimates after a sharp run. Is the market fairly cautious given the recent losses and mixed profitability, or overly wary of the story?
Most Popular Narrative: 11% Undervalued
Against Helmerich & Payne’s last close at $39.64, the most followed narrative anchors fair value at $44.75, leaving a double digit gap that hinges on execution in technology and international drilling programs.
The main thing that has to go right is that Helmerich & Payne continues to convert its technology and global rig deployments, including in Vaca Muerta, the Middle East and offshore, into consistent direct margins and free cash flow while managing cost and conflict risks.
See why 21 investors see Helmerich & Payne as 11% undervalued.
Result: Fair Value of $44.75 (UNDERVALUED)
Still, the Helmerich & Payne story can be knocked off course if drilling overcapacity pressures dayrates, or if conflict related disruptions again hit international margins.
Find out about the key risks to this Helmerich & Payne narrative.
Next Steps
Mixed messages so far or a clear tilt toward optimism on Helmerich & Payne? Move quickly, test the narrative against the numbers yourself, and weigh 3 key rewards and 3 important warning signs.
Looking for more investment ideas beyond Helmerich & Payne?
Do not stop with Helmerich & Payne. Put a wider watchlist to work by testing fresh ideas built from clear data and consistent screening rules.
Source: finance.yahoo.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.
